Titre:
  • Verapamil, a phenylalkylamine Ca2+ channel blocker, inhibits ATP-sensitive K+ channels in insulin-secreting cells from rats.
Auteur:Lebrun, Philippe; Antoine, Marie-Hélène; Ouedraogo, R; Pirotte, B; Herchuelz, André; Cosgrove, Karen E; Kane, C; Dunne, Mark J
Informations sur la publication:Diabetologia, 40, 12, page (1403-1410)
Statut de publication:Publié, 1997-12
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adenosine Triphosphate -- pharmacology
Animals
Calcium -- metabolism
Calcium Channel Blockers -- pharmacology
Calcium Radioisotopes -- metabolism
Female
Gallopamil -- pharmacology
Glucose -- pharmacology
Glyburide -- pharmacology
Hypoglycemic Agents -- pharmacology
Insulin -- secretion
Islets of Langerhans -- drug effects
Islets of Langerhans -- secretion
Potassium Channel Blockers
Potassium Channels -- drug effects
Pyridines -- pharmacology
Rats
Rubidium Radioisotopes -- metabolism
Thiadiazines -- pharmacology
Verapamil -- pharmacology
Note générale:Journal Article
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0012-186X
info:doi/10.1007/s001250050842
info:scp/0031282931
info:pmid/9447947